| Advances in therapeutic Fc engineering - modulation of IgG associated effector functions and serum half-life A Saxena, D Wu Frontiers in Immunology, 7:580, 2016 | 133 | 2016 |
| Fc Engineering for developing therapeutic bispecific antibodies and novel scaffolds H Liu, A Saxena, SS Sidhu, D Wu Frontiers in Immunology, 8:38, 2017 | 114 | 2017 |
| IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients I Koneczny, JAA Stevens, A De Rosa, S Huda, M Huijbers, A Saxena Journal of Autoimmunity 77, 104-115, 2017 | 105 | 2017 |
| IL‐17‐producing CD4+ T cells contribute to the loss of B‐cell tolerance in experimental autoimmune myasthenia gravis H Schaffert, A Pelz, A Saxena, M Losen, A Meisel, A Thiel, S Kohler European journal of immunology 45 (5), 1339-1347, 2015 | 71 | 2015 |
| Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients AM Gomez, N Willcox, K Vrolix, J Hummel, G Nogales-Gadea, A Saxena, ... The Journal of Immunology 193 (3), 1055-1063, 2014 | 48 | 2014 |
| Global HIV-1 molecular epidemiology with special reference to genetic analysis of HIV-1 subtypes circulating in North India: Functional and pathogenic implications of genetic … U Neogi, V Sood, S Banerjee, N Ghosh, S Verma, S Samrat, Y Sharma, ... Indian journal of experimental biology 47 (6), 424, 2009 | 27 | 2009 |
| Characterization of the thymus in Lrp4 myasthenia gravis: Four cases I Koneczny, D Rennspiess, F Marcuse, N Dankerlui, MA Hamid, ... Autoimmunity Reviews 18 (1), 50-55, 2019 | 20 | 2019 |
| Neutralizing antibodies to SARS‐CoV‐2 selected from a human antibody library constructed decades ago M Qiang, P Ma, Y Li, H Liu, A Harding, C Min, F Wang, L Liu, M Yuan, Q Ji, ... Advanced Science 9 (1), 2102181, 2022 | 16* | 2022 |
| Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient A Saxena, J Stevens, H Cetin, I Koneczny, R Webster, K Lazaridis, ... Scientific Reports 7 (1), 14426, 2017 | 16 | 2017 |
| Rapid assessment of binding affinity of SARS-COV-2 spike protein to the human angiotensin-converting enzyme 2 receptor and to neutralizing biomolecules based on computer … D Buratto, A Saxena, Q Ji, G Yang, S Pantano, F Zonta Frontiers in Immunology 12, 730099, 2021 | 11 | 2021 |
| Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells G Nogales-Gadea, A Saxena, C Hoffmann, J Hounjet, D Coenen, ... JoVE (Journal of Visualized Experiments), e52830, 2015 | 8 | 2015 |
| Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder C Hoffmann, J Stevens, S Zong, D van Kruining, A Saxena, Cİ Küçükali, ... Plos one 13 (12), e0208412, 2018 | 7 | 2018 |
| Fc engineering: Tailored synthetic human IgG1-Fc repertoire for high-affinity interaction with FcRn at pH 6.0 A Saxena, B Bai, SC Hou, L Jiang, T Ying, S Miersch, SS Sidhu, D Wu Antibody Engineering: Methods and Protocols, 399-417, 2018 | 1 | 2018 |
| State-of-the-art preclinical evaluation of COVID-19 vaccine candidates D Ghosh, B Bai, Q Ji, S Palliyil, G Yang, A Kumar, A Saxena Exploration of Immunology 1, 440-460, 2021 | | 2021 |
| Physiology and Pathology of Multidrug-Resistant Bacteria: Phage-Related Therapy L Jiang, A Saxena, D Wu Physiology and Pathology of Immunology, 2017 | | 2017 |
| Anti-fungal antibody molecules and uses thereof AJR Porter, M Lenardon, A Saxena WO Patent WO2014174293A1, 2014 | | 2014 |
Mario Losenassistant professor, Maastricht UniversityVerified email at maastrichtuniversity.nl
